7
(CANCER RESEARCH 50, 5257-5262, September 1, 1990] Effect of Guanine and Adenine Nucleotides on Bombesin-stimulated Phospholipase C Activity in Membranes from Swiss 3T3 and Small Cell Lung Carcinoma Cells1 Yoav Sharoni, Jean Viallet, Jane B. Trepel, and Edward A. Sausville2 NCI-Navy Medical Oncology Branch, National Cancer Institute, NIH, Bethesda, Maryland 20814 [Y. S., J. V., J. B. T., E. A. S.]; Faculty of Health Sciences, Ben- Gurion University of the Neger, Beer-Sheva, Israel [Y. S.]; and Department of Medicine, Division of Medical Oncology, Vincent T. Lombardi Cancer Research Center, Georgetown University School of Medicine, Washington, DC 20007 fE. A. S.J ABSTRACT In |3H|inositol-labeled membranes prepared from Swiss mouse 3T3 and human small cell lung carcinoma cells, (Tyr4|-bombesin stimulated production of water-soluble inositol phosphates. The reaction was stim ulated by guanosine 5'-O-[3-thiotriphosphate] and was specifically inhib ited by both [Leu13-^-CH2NHLeu14l-bombesin and the antibombesin antibody 2All. (Tyr4|-homhcsin-ind uccd activation of phospholipase C is most apparent in Ca2+-depleted conditions (<1 pM |Ca2*|frM). The kinetics of activation by ligand also demonstrate that |Tyr4]-bombesin-dependent phospholipase C activation is most apparent at |M¡r+|i,,,of ~0.2 MM.At millimolar concentrations of [M¡r *]rr«, there is considerably less depend ence on [Tyr4)-bombesin for activation of phospholipase C. ATP is not necessary for initial activation of phospholipase C, and /3,-Hmidoadeno- sine-5'-triphosphate does not inhibit the reaction. These results demon strate that in these cell types [Tyi^J-bombesin activates phospholipase C in conjunction with guanine nucleotides. Phospholipase C-coupled guan- ine nucleotide regulatory proteins would be appropriately considered as novel targets for the development of therapeutic strategies in small cell lung carcinoma. INTRODUCTION Bombesin is an amphibian-derived tetradecapeptide which is homologous to the 27-amino acid human GRP3 (1). The latter peptide is produced in 30-60% of human SCLC tumors and derived cell lines (2, 3). Bombesin-like peptides function as secretogogues in gut, pituitary, and pancreas. Bombesin-like immunoreactivity has an extensive distribution in the mam malian central nervous system (4). Mitogenic activity of bom- besin-like peptides has been demonstrated in the case of Swiss mouse 3T3 cells (5), and bombesin congeners can also stimulate clonogenic growth of SCLC in serum-free soft agar (6). Bombesin and GRP stimulate increases in [Ca2+]¡ and PI turnover in Swiss 3T3 cells and SCLC cell lines (7-12). The latter events occur after activation of a hormone receptor- coupled phospholipase C activity, which causes initial hydrol ysis of phosphatidylinositol-4,5-bisphosphate. Inositol tris- phosphates and inositol tetrakis-, bis-, and monophosphates Received 3/1/90; revised 5/24/90. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. ' Supported in part by Biomedicai Research Support Grant RR 5360 to Georgetown University School of Medicine from the NIH. 2To whom requests for reprints should be addressed, at Medicine Branch, National Cancer Institute, National Institutes of Health, Bldg. 10.. Room 12N228, 9000 Rockville Pike, Bethesda, MD 20892. 3The abbreviations used are: GRP, gastrin-releasing peptide; App(NH)p, ßy- imidoadenosine-5-triphosphate; [Ca2*]fr„, free calcium concentration; [Ca2*]¡, in- tracellular free calcium concentration; EGTA, [ethylenebis(oxyethylene nitrilo)] tetraacetic acid; G protein, guanine nucleotide-binding protein; (;,. inhibitory guanine nucleotide-binding protein of adenylate cyclase: G,, stimulatory guanine nucleotide-binding protein of adenylate cyclase; GDP/3S, guanosine 5'-O-[2- thiodiphosphate]; GTP^S, guanosine 5'-O-[3-thiotriphosphate]; IPj. inositol tris- phosphate; 1P2, inositol bisphosphate: IP,, inositol monophosphate; [Mg2*]fr„, free magnesium concentration; PDGF, platelet-derived growth factor; PI, phos- phatidylinositol; PMSF, phenylmethylsulfonylfluoride; SCLC, small cell lung carcinoma; [Tyr'j-BN. [Tyr4]-bombesin. are subsequently formed. Determination of whether autocrine stimulation of these events in SCLC depends only on secretion of active peptides or whether deregulation of cellular responses to GRP is present in SCLC requires an understanding of the intracellular effectors of GRP action in SCLC. In a variety of systems where hormonal activation proceeds through increases of [Ca2+]¡, including 5-hydroxytryptamine- stimulated blowfly salivary glands (13), thrombin-stimulated platelets (14), vasopressin-stimulated liver (15, 16), thyrotro- pin-releasing hormone-stimulated anterior pituitary cells (17- 19), and chemoattractant-stimulated polymorphonuclear neu- trophils (20), activation of phospholipase C appears to be mediated by a G protein (21, 22). The participation of a G protein in bombesin-mediated signalling had initially been sug gested by Letterio et al. (23), who demonstrated that pertussis toxin blocked bombesin-induced but not PDGF-induced in creases in c-myc and DNA synthesis in Swiss 3T3 cells. This finding raised the possibility that a pertussis toxin-sensitive G protein regulated bombesin-induced intracellular responses. Subsequent studies have clearly shown, however, that pertussis toxin does not efficiently inhibit early events after bombesin stimulation, such as increases in [Ca2+]¡ or inositol phosphates in Swiss 3T3 or SCLC cells (24, 25). Thus, whether a G protein participates in bombesin-mediated activation of phospholipase C has been unclear. We therefore undertook this study to determine if phospho lipase C activation by bombesin in human SCLC as well as in murine fibroblasts proceeded through a guanine nucleotide- sensitive process. This was accomplished by studying the effects of guanine nucleotides on bombesin agonist-specific activation of phospholipase C in cell membrane fractions. MATERIALS AND METHODS Reagents and Cells. [Tyr"]-BN was purchased from Peninsula; myo- [3H]inositol (16 Ci/mmol), [3H]IP„[3H]IP2, [3H]IP3, and Aquassure scintillation fluid from New England Nuclear; and GTP-yS and GDP/3S from Boehringer Mannheim. App(NH)p, ATP, and all other reagents unless indicated were from Sigma. The bombesin antagonist [Leu13-^- CH2NH-Leu'4]-bombesin (26) was a gift from Dr. J. Moreau (Biomea- sure, Hopkinton, MA). Antibombesin monoclonal antibody 2A11 (27) was a gift of Dr. Frank Cuttitta (NCI-Navy Medical Oncology Branch, Bethesda, MD). Swiss mouse 3T3 cells were grown as monolayers in 175-cm2 flasks in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum, 100 units/ml penicillin, 100 ug/m\ streptomycin, and 20 Mg/ml amphotericin. Human SCLC cells NCI-H345 and NCI- N417 were established from clinically derived specimens (2) and main tained in suspension in RPMI 1640 medium supplemented with 20 m\i 4-(2-hydroxyethyl)-l-piperazineethanesulfonic acid, 5 Mg/ml insu lin, 10 Mg/ml transferrin, 0.03 MM sodium selenite, and the same antibiotics as above. Membrane Preparation and Phospholipase C Assay. For preparation of labeled membranes, 3T3 cells were plated in 150-mm plates (6 x IO5 cells/plate) and grown for 6 days. The cells reached confluence by the 4th to 5th day. During the last 3 days, the medium contained 10 5257 on June 3, 2021. © 1990 American Association for Cancer Research. cancerres.aacrjournals.org Downloaded from

Effect of Guanine and Adenine Nucleotides on Bombesin ... · novel targets for the development of therapeutic strategies in small cell lung carcinoma. INTRODUCTION Bombesin is an

  • Upload
    others

  • View
    4

  • Download
    0

Embed Size (px)

Citation preview

  • (CANCER RESEARCH 50, 5257-5262, September 1, 1990]

    Effect of Guanine and Adenine Nucleotides on Bombesin-stimulated Phospholipase

    C Activity in Membranes from Swiss 3T3 and Small Cell Lung CarcinomaCells1

    Yoav Sharoni, Jean Viallet, Jane B. Trepel, and Edward A. Sausville2

    NCI-Navy Medical Oncology Branch, National Cancer Institute, NIH, Bethesda, Maryland 20814 [Y. S., J. V., J. B. T., E. A. S.]; Faculty of Health Sciences, Ben-Gurion University of the Neger, Beer-Sheva, Israel [Y. S.]; and Department of Medicine, Division of Medical Oncology, Vincent T. Lombardi Cancer Research Center,Georgetown University School of Medicine, Washington, DC 20007 fE. A. S.J

    ABSTRACT

    In |3H|inositol-labeled membranes prepared from Swiss mouse 3T3and human small cell lung carcinoma cells, (Tyr4|-bombesin stimulatedproduction of water-soluble inositol phosphates. The reaction was stimulated by guanosine 5'-O-[3-thiotriphosphate] and was specifically inhibited by both [Leu13-^-CH2NHLeu14l-bombesin and the antibombesinantibody 2All. (Tyr4|-homhcsin-ind uccd activation of phospholipase C ismost apparent in Ca2+-depleted conditions (

  • BOMBESIN-STIMULATED PHOSPHOLIPASE C

    ml /7iyo-['H]inositol. Human SCLC cells were labeled for 5 days inKI'MI 1640 medium formulated without inositol, supplemented asdescribed for cell culture, with addition of 5 ¿¿Ci/mlmj-o-[]H]inositol.

    SCLC were harvested by centrifugation, and 3T3 cells were scrapedinto their media, washed once in 0.15 M NaCl, 0.015 M Na phosphate,pH 7.4, and once in a buffer containing 50 mM Tris-HCl (pH 8.0), 1miMEGTA, 2 mM MgCl2, 2 Mg/ml leupeptin, and 0.5 miviPMSF. Cellswere resuspended at 4°Cin 2 ml/plate homogenization buffer formu

    lated as above but with 20 mM Tris-HHCl. After 10 min, the cellsuspension was homogenized with a Teflon and glass homogenizer andcentrifuged at 800 x g for 5 min. The pellet was homogenized again inhalf the original volume and the combined supernatant was centrifugedat 40,000 x g for 10 min. The pellet was resuspended in 40 mM Tris-HCl (pH 6.9), 1 mM EGTA, 10 mM LiCl, 4 //g/ml leupeptin, and 0.5mM PMSF. Membranes were maintained on ice and used directlywithout freezing.

    Incubation of the membrane suspension for measurement of phos-pholipase C activity was done essentially as described by SträubandGershengorn (28). Unless otherwise noted in the figure legends, 20 ¿il(20-50 ng of membrane protein) of membranes were added to obtain100 n\ with the following conditions: 40 mM Tris (pH 6.9), 2 mMEGTA, 2 mM EDTA, 10 mM LiCl, 2 ¿ig/mlleupeptin, 0.5 mM PMSF,1 mM ouabain, 2 mM dithiothreitol, 2 mM ATP, and 6 mM MgCl2 (2mM [Mg2+'fr„or no added MgCl2 (0.2 UM [Mg2*]fre«).[Ca2*]frrewasadjusted to 0.1 ¿¿Mwith CaCl2. The [Ca2*]fr„and [Mg2*)rretwere calcu

    lated using the computer program described by Jean and Klee (29).All components except the membranes were preincubated at 37°C

    for 2 min. After addition of the membranes, the reaction was continuedfor 1 min unless otherwise indicated and was terminated by addition of1 ml of CHC13/CH,OH/HC1 (100/100/1). Phases were separated byaddition of 0.25 ml of 0.01 M EDTA, vigorous mixing, and centrifugation. An aliquot (0.7 ml) of the aqueous phase was added to 5 ml ofHjO, neutralized with 50 ^1 of l M NaOH, and adsorbed to Dowex 1as described (30). IP, was eluted with 0.1 M formic acid/0.2 M ammonium formate, IP2 was eluted with 0.1 M formic acid/0.4 M ammoniumformate, and IP3 was eluted with 0.1 M formic acid/0.75 M ammoniumformate. Six-mi fractions were mixed with 12 ml Aquassure and conversion to dpiii accomplished using a series of quenched standards afterscintillation counting.

    RESULTS

    Phospholipase C in Membrane Fractions. In a typical membrane preparation incubated without other additions for 1 minat 37°C,the ['HJinositoI label in the IP, fraction did not change,

    while the IP2 and IP., fractions increased from 14 to 22% and5 to 6% of the label, respectively. While accumulation of IP2may reflect direct hydrolysis of phosphatidylinositol-4-phos-phate, IP2 may also arise by degradation of IP.,. The latterprocess was clearly evident in the membrane preparation, because addition of ['H]IP, demonstrated a rate of hydrolysis ofIP., to IP2 of 0.1 pmol/min with 1 ¿¿MIP, and no added Mg2*and 40 pmol/min with 10 MMIP.i and 2 mM [Mg2+]frcc.Thus,our results will be presented as dpm in the inositol polyphos-phate (IP2 plus IP.,) fraction after agonist treatment.

    Stimulation of Phospholipase C by Bombesin and GTP-yS.Fig. 1 demonstrates that addition of the bombesin agonist [Tyr4]-BN (100 nM) to ['Hjinositol-labeled Swiss 3T3 membranes inthe absence of added Mg2+, followed by incubation for I min,

    causes a small increase in inositol poly phosphates, as does 10Õ/MGTPiS. However, GTP>S and [Tyr4]-BN at the above

    concentrations together act to increase inositol polyphosphatesto a 2-fold greater extent than the sum of the separate effects.

    Stimulation of phospholipase C by [Tyr4]-BN in the presenceof 10 n\\ GTP-yS is concentration dependent, with maximalactivation at about 1000 n\i and half-maximal activation at 10nM (Fig. 1). Activation of phospholipase C by [Tyr4]-BN and

    10 100 1000

    [Tyr4-BN] nMFig. I. Stimulation of phospholipase C activity by [Tyr4]-BN and GTP-yS:

    inhibition by a bombesin antagonist. [3H|Inositol-labeled Swiss 3T3 membranes(32 >S was detected as early as 8 s (not shown), which was theshortest possible time for the assay. The capacity of 100 nM[Tyr4]-BN to increase phospholipase C activity is specificallyinhibited by 10 MMof the antagonist [Leu"--¿-CH2NH-Leu14]-

    bombesin. The inhibition by this antagonist is partially reversedby increasing the [Tyr4]-BN to 1000 nM.

    As shown in Fig. 2, [Tyr4]-BN also activates phospholipase

    C in membranes derived from the SCLC cell line NCI-H345 inthe presence of 10 MMGTP-yS. Fig. 2 also demonstrates the

    specificity of the interaction of these membranes for the bombesin agonist. Inclusion of the monoclonal antibody 2AI1 (50Mg/ml) directed against bombesin in the incubation completelyabolished the ligand-stimulated phospholipase C activity, reducing it to the value achieved with 10 MMGTP7S alone. Thisinhibition was evident up to a concentration of 100 nM [Tyr4]-BN but was partially reversed by an increase of the [Tyr4]-BN

    concentration to 1000 nM.Effect of GDP/3S and Fluoride. The experiments presented in

    Fig. 1 suggest that an element responsive to guanine nucleotideparticipates in bombesin-mediated signal transduction. Fig. 3demonstrates using Swiss 3T3 membranes that the inclusion of1 mM GDP/3S inhibits basal phospholipase C activity and theactivity stimulated by [Tyr4]-BN alone, by GTP-yS alone, and

    5258

    on June 3, 2021. © 1990 American Association for Cancer Research. cancerres.aacrjournals.org Downloaded from

    http://cancerres.aacrjournals.org/

  • BOMBESIN-STIMULATED PHOSPHOLIPASE C

    6000 -i • no addition

    ! ÃœGDPUS ImM

    5."3CO

    CUrç 600 -

    800 -

    400 -

    200 -

    basai Tyr4BN GTPyS GTP|S +

    l|iM lOuM Tyr BN

    Al-F

    Fig. 3. Inhibition of basal, [Tyr4)-BN-stimulated. and GTP-xS-stimulatedphospholipase C activity by GDPfÃ-S.Reactions with ['Hjinositol-labeled Swiss3T3 membranes (28 ng) were conducted in duplicate, as described in the legendto Fig. 1. Incubations under the control conditions (basal) or with the indicatedconcentrations of [Tyr4l-BN and GTP-yS were with 0.2 »IM|Mg!*]fr„.For the[ALF4|~ complex (Al-F), 10 UM AlClj and 10 mM NaF were incubated in areaction with 2 mM [Mg2*)fr„in the absence (darker bars] or presence of I mM

    GDP0S (lighter bars).

    2110(1,

    5.—

    100(1.

    O basal

    • GTPyS+Tyr4-BN

    10"'10 10

    |Ca'2+]free(M)

    10'

    Fig. 4. Effect of |Ca2*] on phospholipase C activity. Reactions with [JH|inositol-labeled Swiss 3T3 membranes (22 ng) were conducted in duplicate, asdescribed in the legend to Fig. 1. To achieve [Ca2*]rretat or below 10~' M, 8 mMEGTA was added. Two mM EGTA was used at all other |Ca2*| concentrations.The MgClz concentration was adjusted to give about 2 mM [Mg2*]r„,at all Ca2*concentrations. Incubations were with no additions (O) or with 10 UMGTP-ySplus 1000 nM [Tyr'l-BN (•).

    by [Tyr4]-BN plus GTP7S. Inhibition of the basal activity andof the [Tyr4]-BN-stimulated activity by GDP/3S to a similar

    level suggests that phospholipase C activation achieved withoutaddition of GTP7S is probably attributable to the presence ofendogenous guanine nucleotides in the membrane fraction.

    Phosphatidylinositide hydrolysis can be stimulated in a li-gand-independent fashion by [A1F4]~.This species is postulated

    to activate G proteins by mimicking the terminal phosphate ofGTP, without being subject to hydrolysis, resulting in persistentG protein activation (31). It can be seen in Fig. 3 that theactivity in the presence of 10 ^M AlClj and 10 mM NaF wasnot significantly inhibited by GDP/3S.

    Effect of Ca2* and Mg2*. Phosphatidylinositide hydrolysiswas specifically activated by guanine nucleotides and [Tyr4]-bombesin only when [Ca2*]freewas below 10~6M (Fig. 4). Higher

    calcium concentrations increased the basal activity to suchlevels that the addition of GTP7S and [Tyr4]-BN did not cause

    any additional effect. Activation of phospholipase C by GT?7Splus [Tyr4]-BN was evident ad [Ca2+]freebelow 10~9 M, which

    was achieved with 8 mM EGTA. This activation was maximalat about 10~7M [Ca2+]free,which is the concentration used in all

    other experiments.Since guanine nucleotides may act as a Mg-GTP complex,

    the effect of [Mg2*] on the activation of phospholipase C was

    examined (Fig. 5). In membranes from Swiss 3T3 cells, basaland GTP7S-stimulated phospholipase C activity was greater inthe presence of 2 mM [Mg2*]frcc,as compared with 0.2 /¿M[Mg2*]frec.However, [Tyr4]-BN-dependent stimulation of phospholipase C was much more evident at 0.2 /tM [Mg2*]frccthan

    1

    -

    3

    3000 -i

    2000 -

    1000 -

    I basal

    D GTPyS

    •

    1

    GTPyS + Tyr -BN

    [Mg: 0.2nM 2mMCell line: Swiss 3T3

    2mMNCI-H345

    0.2nM 2mMNCI-N417

    Fig. 5. Effect of Mg2* on phospholipase C activation in Swiss 3T3 and SCLCcell lines. Reactions with ['Hjinositol-labeled membranes were conducted in

    triplicate, as described in the legend to Fig. 1. Results are the average ±SE of 10experiments with Swiss 3T3 cells, 6 experiments with NCI-H345, and 2 withNCI-H417. The results were normalized to the same total radioactivity in membranes per assay to allow calculation of average and SE and to allow comparisonof the three cell lines.

    at 2 mM [Mg2+]free.With 2 mM [Mg2+]free,addition of 1 n\t[Tyr4]-BN causes only small additional stimulation of the activity (1.4-fold that evoked by GTP>S alone). By contrast, at 0.2fiM [Mg2+]frce,the addition of [Tyr4]-BN caused a larger stimu

    lation (3.5-fold the activation by GTP7S alone). Entirely analogous results, particularly the dependence on low [Mg2*] fordemonstration of optimal [Tyr4]-BN activation, are shown inFig. 5 for the bombesin-responsive SCLC cell line NCI-H345.In contrast, in the bombesin nonresponsive SCLC cell lineNCI-N417 the activation by GT?7S is similar to the other twocell lines, but there was no response to bombesin of the membrane fraction at either 0.2 ¿ÌMor 2 mM [Mg2+]free.

    Kinetics of Phospholipase C Activation by GTP7S and |Tyr4]-

    BN. Since the experiments of Fig. 5 suggest an importantinfluence of Mg2+ in regulating response to [Tyr4]-BN, furtherexamination of the role of Mg2+ was undertaken. In order to

    follow the onset of activation, the incubation temperature wasreduced to 25°C,since at 37°Cthe reaction was at maximal

    velocity at the earliest possible measurement (8 s; not shown).At 0.2 fiM [Mg2+]fre(.and with GTP7S alone, a significant lag

    phase is observed prior to phospholipase C activation (Fig. 6a).In contrast, at 0.2 ¿IM[Mg2+]fre

  • BOMBESIN-STIMULATED PHOSPHOLIPASE C

    a. |Mg++M).2uM

    time (sec)Fig. 6. Time course of activation of phospholipase C by [Tyr']-BN and GTP>S.

    Reactions with [JH)inositol-labeled Swiss 3T3 membranes (33 jjg) were conductedin duplicate, as described in the legend to Fig. 1 but at 25°C.The experiment

    shown is one of three similar experiments. The IP2 plus IP3 formed in the controlincubation at the indicated time points was subtracted from the results with 10>iMGTP-xS (O) or with GTP>S plus 100 nM [Tyi"]-BN (•).

    1500-

    1000-

    500 -i

    1500-

    1000 H

    500 i

    basalTyr4BNGTP-ßGTPi6+Tyr4BN

    b.[Mg++]=2mM

    •

    ATP no ATP APP(NH)PFig. 7. Effect of adenine nucleotidcs on phospholipase C activation. Reactions

    with [3H]inositol-labeled Swiss 3T3 membranes (27 ^g) were conducted in dupli

    cate, as described in the legend to Fig. 1. The omission of ATP was taken intoaccount when calculating the concentration of [CaI*]r«.and |Mg!*]r,„.The|Mg2*]r,„in a and b is shown. App(NH)p was added at the same concentration

    as ATP (2 mm).

    the absence of ATP, especially with high [Mg2+]frce,whereas thebasal activity is 2-fold higher in the presence of ATP. Theactivation of phospholipase C by GTP7S and [Tyr4]-BN was

    not affected by the omission of ATP. The replacement of ATPby App(NH)p, a nonhydrolyzable analogue of ATP, does notinhibit the GTP^S- and [Tyr4]-BN-stimulated activation of

    phospholipase C.

    DISCUSSION

    Although it is clear that bombesin-like peptides transducesignals using a calcium- and inositol-related signal transductionpathway (7-12), the mechanism of this process has not yet beenelucidated. Initial experiments showed that pertussis toxin inhibited bombesin-mediated DNA synthesis (23) but not phospholipase C activation (11, 24, 25). Inhibition by pertussis toxinof bombesin-stimulated DNA synthesis was partially reversedby concomitant insulin treatment (24). These results could beinterpreted to indicate that a G protein-mediated step occursafter phospholipase C activation. However, Fischer and Schon-brunn (32) have demonstrated a decrease in the affinity ofbombesin congeners for membranes from a variety of cell types

    by incubation with guanine nucleotides. Inhibition by guaninenucleotides of agonist binding was not reversed by treatmentwith pertussis or cholera toxin. These latter results, therefore,argue in favor of the existence of a cholera and pertussis toxin-insensitive G protein which would participate in bombesin-induced signal transduction. Further evidence in favor of thispoint of view includes the recent observation (33) in permeabi-lized Swiss 3T3 cells that nonhydrolyzable guanine nucleotideanalogues potentiate the appearance of bombesin-dependentand protein kinase C-mediated M, 80,000 protein phosphoryl-ation. Hasegawa-Sasaki et al. (34) have also shown stimulationby GTP of bombesin and vasopressin but not PDGF-stimulatedinositol phosphate production in WFB rat fibroblast membranes.

    The experiments presented here extend these observations tomembrane fractions derived from murine Swiss 3T3 cells andhuman SCLC cells. In addition, the experiments presented heredemonstrate that, in membranes from both types of cell, poten-tiation of phospholipase C by bombesin and GTP-yS occurredwith greatest dependence on added ligand at

  • BOMBESIN-STIMULATED PHOSPHOLIPASE C

    phospholipase C. Bombesin, however, did not induce this phos- REFERENCESphorylation. Margolis et al. (42) have demonstrated that thetyrosine kinase antagonist tyrphostin inhibited epidermalgrowth factor-induced increases in [Ca2+]¡in HER cells but notthe increase in [Ca2+]¡induced by bombesin or bradykinin. In

    contrast, Cirillo et al. (43) have presented evidence that bombesin treatment of Swiss 3T3 cells results in tyrosine phos-phorylation of a M, 115,000 membrane-associated protein.Isacke et al. (44), however, did not observe increases in totalcellular tyrosine phosphates after bombesin treatment, andaffinity cross-linking studies (45, 46) have clearly shown thatbombesin cross-linked to a M, ~75,000 heavily glycosylatedspecies. A clear demonstration of kinase activation as an obligatory step in bombesin-mediated signalling has, therefore, notyet been shown. In our experiments, the inclusion of ATP or anon-hydrolyzable analogue of ATP did not influence bombesin-stimulated phospholipase C activation. While this result isconsistent with the observations of Margolis et al. (42), adetermination of whether a kinase participates in bombesinreceptor-mediated signalling must await better structural characterization of the receptor.

    The influence of bombesin or its antagonists on the proliferation of SCLC is controversial. Takuwa et al. (47) and Laytonet al. (48) demonstrated no influence of bombesin agonists onDNA synthesis of SCLC grown in liquid mass culture. Thebombesin antagonists [D-Arg',D-Phes,D-Trp7-9,Leu"]-substanceP and [D-Arg',D-Pro2,D-Trp7-9,Leu"]-substance P inhibitedDNA synthesis at high (~10~4M) concentrations (47-49). Thebombesin antagonist [Leu"-i¿-CH2NH,Leu'4]-bombesin inhib

    ited SCLC proliferation at 1 /¿Mconcentration [where it wasshown to inhibit bombesin-mediated signal transactions (50)]only in serum-free soft agar cloning and did not inhibit SCLCproliferation in liquid media.4 An inherent difficulty, however,is the stability or accessibility of bombesin-related antagoniststo the bombesin receptor in the liquid culture system, becauseSCLC tend to grow in large clumps of adherent cells. Also, asoutlined by Takuwa et al. (47) and Woll and Rozengurt (51),SCLC can respond biochemically to a variety of neuropeptides.Thus, blockade of several receptors may be necessary to inhibitgrowth-stimulatory influences definitively. Definition of elements of the bombesin-related signal transduction pathwaycould reveal a common pathway of activation used by otherneuropeptides.

    The experiments presented here offer independent corrobo-ration of the importance of a guanine nucleotide-mediatedpathway in bombesin-induced signalling in murine fibroblastand lung carcinoma cell lines. [Tyr"]-BN in the presence of the

    nonhydrolyzable GTP analogue GTP7S potentiated phospholipase C activity, which was specifically inhibited by a bombesinantagonist and a bombesin-specific monoclonal antibody.GDP0S inhibited this process. The presence or absence of ATPor App(NH)p did not influence the reaction. Further experiments will focus on identifying the G protein active in thetransduction of the bombesin signal. Therapeutic agents whichcould disrupt the coupling of this G protein to intracellularsignals or uncouple it from the hormone receptor could be ofgreat interest in the development of novel approaches to thetherapy of SCLC.

    ACKNOWLEDGMENTS

    The authors acknowledge the support of Drs. Marc Lippman andJohn Minna during the course of this work and the thoughtful comments of Drs. Jorge Laborda and Peter Worland.

    10.

    11.

    12.

    13.

    14.

    15.

    16.

    17.

    18.

    19.

    20.

    21.

    22.

    23.

    24.

    25.

    ' J. Viallet, unpublished results. 26.

    5261

    McDonald, T. J., Jornvall, H.. Nilsson, G., Vagne, M., Ghalei. M., Bloom.S. R., and Mutt, V. Characterization of a gastrin releasing peptide fromporcine non-antral gastric tissue. Biochem. Biophys. Res. Commun., 90:227-233, 1979.Carney. D. N.. Gazdar, A. F.. Bepler. G., Guccion, J. G., Marangos, P. J..Moody, T. W., Zweig, M. H., and Minna. J. D. Establishment and identification of small cell lung carcinoma cancer cell lines having classic and variantfeatures. Cancer Res.. 45: 2913-2923, 1985.Sausville, E. A., Lebacq-Verheden, A., Spindel, E. R., Cuttitta, F., Gazdar,A. F., and Battey. J. F. Expression of the gastrin-releasing peptide gene inhuman small cell lung cancer. J. Biol. Chem.. 261: 2451-2457. 1986.Panula. P.. Nieminen, O., Falkenburg. M., and Auvinen, S. Localization anddevelopment of bombesin/GRP-like immunoreactivity in the rat centralnervous system. Ann. NY Acad. Sci., 547: 54-69. 1988.Rozengurt, E., and Sinnett-Smith, J. Bombesin stimulation of DNA synthesisand cell division in cultures of Swiss 3T3 cells. Proc. Nati. Acad. Sci. USA,«0:2936-2940, 1983.Carney. D. N., Cuttitta. F., Moody, T. W., and Minna. J. D. Selectivestimulation of small cell lung cancer clonal growth by bombesin and gastrin-releasing peptide. Cancer Res., 47: 821-825, 1987.Heslop, J. P., Blakely, D. M., Brown. K. D., Irvine, R. F., and Berridge, M.J. Effects of bombesin and insulin on inositol (l,4,5)trisphosphate andinositol (l,3,4)trisphosphate formation in Swiss 3T3 cells. Cell, 47: 703-709. 1986.Takuwa, N., Takuwa, Y., Bollag, W. E., and Rasmussen. H. The effects ofbombesin on polyphosphoinositide and calcium metabolism in Swiss 3T3cells. J. Biol. Chem., 262: 182-188. 1987.Zachary, I., Sinnett-Smith, J. W., and Rozengurt, E. Early events elicited bybombesin and structurally related peptides in quiescent Swiss 3T3 cells. I.Activation of protein kinase C and inhibition of epidermal growth factorbinding. J. Cell Biol., 102: 2211-2221. 1986.Heikkilla, R.. Trepel, J. B.. Cuttitta, F., Neckers, L. M., and Sausville. E. A.Bombesin-related peptides induce calcium mobilization in a subset of humansmall cell lung cancer cell lines. J. Biol. Chem., 262: 16456-16460, 1987.Trepel, J., Moyer. J., Heikkila, R., and Sausville, E. Modulation of bombesin-induced phosphatidylinositol hydrolysis in a small cell lung-cancer cell line.Biochem. J., 255: 403-410, 1988.Swope, S., and Schonbrunn, A. The biphasic stimulation of insulin secretionby bombesin involves both cytosolic free calcium and protein kinase C.Biochem. J.. 253: 193-202, 1988.Litosch, 1., Wallis, C., and Fain, J. N. 5-Hydroxytryptamine stimulatesinositol phosphate production in cell-free system from blowfly glands: evidence for a role of GTP in coupling receptor activation to phosphoinositidebreakdown. J. Biol. Chem., 260: 5464-5471, 1985.Rebecchi, M., and Rosen, O. Stimulation of polyphosphoinositide hydrolysisby thrombin in membranes from human fibroblasts. Biochem. J., 245: 49-57, 1987.Uhing. R. J., Prpic, V., Jiang, H., and Exton, J. H. Hormone-stimulatedpolyphosphoinositide breakdown in rat liver plasma membranes. J. Bio).Chem., 261: 2140-2146, 1986.Fitzgerald, T. J., Uhing. R. J., and Exton, J. H. Solubilization of thevasopressin receptor from rat liver plasma membranes. J. Biol. Chem., 267:16871-16877, 1986.Hinkle. P. M., and Kinsella, P. A. Regulation of thyrotropin-releasinghormone binding by monovalent cations and guanyl nucleotides. J. Biol.Chem.. 259: 3445-3449, 1984.Aub, D. L., Frey. E. A., Sekura, R. D., and Cote, T. E. Coupling of thethyrotropin releasing hormone factor to phospholipase C by a GTP-bindingprotein distinct from the inhibitory or stimulatory GTP-binding protein. J.Biol. Chem., 267: 9333-9340, 1986.Martin, T. F. J., Lucas. D. O,. Bajjalieh, S. M., and Kowalchyk. J. A.Thyrotropin-releasing hormone activates a Ca2*-dependent polyphosphoi

    nositide phosphodiesterase in permeable GH3 cells. J. Biol. Chem., 267:2918-2927, 1986.Smith. C. D., Lane, B. C., Kusaka, I., Verghese, M. W., and Snyderman, R.Chemoattractant receptor-induced hydrolysis of phosphatidylinositol 4,5-bisphosphate in human polymorphonuclear leukocyte membranes. J. Biol.Chem., 260: 5875-5878, 1985.Cockroft. S. Polyphosphoinositide phosphodiesterase: regulation by a novelguanine nucleotide binding protein Gp. Trends Biochem. Sci., 72: 75-78,1987.Fain, J. N., Wallace. M. A., and Wojcikiewicz, R. J. H. Evidence forinvolvement of guanine nucleotide-binding regulatory proteins in the activation of phospholipases by hormones. FASEB J., 2: 2569-2574, 1988.Letterio, J. J., Coughlin, S. R., and Williams, L. T. Pertussis toxin-sensitivepathway in the stimulation of c-myc expression and DNA synthesis bybombesin. Science (Washington, DC). 234: 1117-1119, 1986.Zachary, I., Millar, J.. Nanberg, E., Higgins. T.. and Rozengurt, E. Inhibitionof bombesin-induced milogenesis by pertussis toxin: dissociation from phos-pholipase-C pathway. Biochem. Biophys. Res. Commun., 146: 456-463,1987.Taylor. C. W., Blakely. D. M., Corps, A. N., Berridge, M. J., and Brown, K.D. Effects of pertussis toxin on growth factor-stimulated inositol phosphateformation and DNA synthesis in Swiss 3T3 cells. Biochem. J., 249: 917-920. 1988.Coy. D. H., Heinz-Erian. P., Jiang, N.. Sasaki. Y.. Taylor. J., Moreau. J..

    on June 3, 2021. © 1990 American Association for Cancer Research. cancerres.aacrjournals.org Downloaded from

    http://cancerres.aacrjournals.org/

  • BOMBESIN-STIMULATED PHOSPHOLIPASE C

    Wolfrey. W. T., Gardner, J. D., and Jensen. R. T. Probing peptide backbonefunction in bombesin. J. Biol. Chem.. 263: 5056-5060, 1988.

    27. Cuttitta, F., Carney, D. N., Mulshine. J., Moody, T. W., Fedorko, J.. Fischler.A., and Minna, L. D. Bombesin-like peptides can function as autocrinegrowth factors in human small cell lung cancer. Nature (Lond.). 316: 823-

    826. 1985.28. Sträub.R. E., and Gershengorn, M. Thyrotropin-releasing hormone and

    GTP activate inositol trisphosphate formation in membranes isolated fromrat pituitary cells. J. Biol. Chem., 261: 2712-2717, 1986.

    29. Jean, T.. and Klee. C. B. Calcium modulation of inositol 1,4.5-trisphosphate-induced calcium release from neuroblastoma x glioma hybrid (NG108-15)microsomes. J. Biol. Chem., 261: 16414-16420. 1986.

    30. Berridge. M. J.. Downes, C. P.. and Hanley. M. R. Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands.Biochem. J.. 206: 587-595. 1982.

    31. Bigay, J.. Deterre, P., Pfister, C.. and Chabre. M. Fluoroaluminates activatetransducin-GDP by mimicking the -y-phosphate of GTP in its binding site.FEBS Lett., 191: 181-185, 1985.

    32. Fischer. J., and Schonbrunn, A. The bombesin receptor is coupled to aguanine nucleotide-binding protein which is insensitive to pertussis andcholera toxins. J. Biol. Chem.. 263: 2808-2816. 1988.

    33. Erusalimsky. J. D.. Friedberg, 1., and Rozengurt, E. Bombesin, diacylglyc-erols. and phorbol esters rapidly stimulate the phosphorylation of an M, =80.000 protein kinase C substrate in permeabilized 3T3 cells. J. Biol. Chem.,263: 19188-19194. 1988.

    34. Hasegawa-Sasaki, H., Lutz, F., and Sasaki, T. Pathway of phospholipase Cactivation initiated with platelet-derived growth factor is different from thatinitiated with vasopressin and bombesin. J. Biol. Chem.. 263: 12970-12976.1988.

    35. Gilman, A. G Proteins: transducers of receptor-generated signals. Annu. Rev.Biochem., 56: 615-649. 1987.

    36. Birnbaumer. L.. Codina. J.. Matterà . R.. Cerione. R. A., Hildebrandt, J. D.,Sunyer, T., Rojas, F. J., Carón. M. G.. Lefkowitz, R. J.. and lyengar, R.Regulation of hormone receptors and adenylyl cyclases by guanine nucleotidebinding N proteins. Recent Prog. Horm. Res., 41: 41-94, 1985.

    37. lyengar, R.. and Birnbaumer, L. Hormone receptor modulates the regulatorycomponent of adenyl cyclase by reducing its requirement for Mg!* and

    enhancing its extent of activation by guanine nucleotides. Proc. Nati. Acad.Sci. USA, 79:5179-5183, 1982.

    38. Hall, A., and Self, A. J. The effect of Mg2* on the guanine nucleotideexchange rate of p21N"".J. Biol. Chem.. 261: 10963-10965. 1986.

    39. Wolfman. A., Moscucci. A., and Macara, I. Evidence for multiple, raj-like,guanine nucleotide-binding proteins in Swiss 3T3 plasma membranes. J.

    Biol. Chem.. 264: 10820-10827, 1989.40. Wahl. M. I.. Olashaw, N. E., Nishibe, S., Rhee. S. G., Pledger, W. J.. and

    Carpenter, G. Platelet-derived growth factor induces rapid and sustainedtyrosine phosphorylation of phospholipase-C in quiescent BALB/c 3T3 cells.Mol. Cell. Biol., 9: 2934-2943. 1989.

    41. Meisenhelder. J.. Suh, P.. Rhee, S. G., and Hunter. T. Phospholipase-C is asubstrate for the PDGF and EGF receptor protein-tyrosine kinases in vivoand in vitro. Cell. 57: 1109-1122. 1989.

    42. Margolis, B., Rhee. S. G.. Felder, S., Mervic, M.. Lyall. R., Levitzki. A.,Ullrich. A.. Zilberstein. A., and Schlessinger, J. RGF induces tyrosinephosphorylation of phospholipase C-II: a potential mechanism for EGFreceptor signalling. Cell, 57: 1101-1107, 1989.

    43. Cirillo. D. M., Caudino, G., Naldini. L., and Comoglio. P. Receptor forbombesin with associated tyrosine kinase activity. Mol. Cell. Biol., 6: 4641-4649, 1986.

    44. Isacke, C. M., Meisenhelder. J.. Brown. K. D., Gould. K. L.. Gould, S. J.,and Hunter, T. Early phosphorylation events following the treatment ofSwiss 3T3 cells with bombesin and the mammalian bombesin-related peptide.gastrin-releasing peptide. EMBO J.. 5: 2889-2898. 1986.

    45. Kris. R. M.. Hazan, R., Villines, J., Moody. T. W.. and Schlessinger, J.Identification of the bombesin receptor on murine and human cells by cross-linking experiments. J. Biol. Chem.. 262: 11215-11220. 1987.

    46. Zachary, I., and Rozengurt. E. Identification of a receptor for peptides of thebombesin family in Swiss 3T3 cells by affinity cross-linking. J. Biol. Chem.,262:3947-3950, 1987.

    47. Takuwa, N., Takuwa, Y.. Ohue. Y.. Mukai. H.. Endoh, K., Yamashita, K.,Kumada, M.. and Munekata, E. Stimulation of calcium mobilization but notproliferation by bombesin and tachykinin neuropeptides in human small celllung cancer cells. Cancer Res., 50: 240-244. 1990.

    48. Layton. J. E., Scanlon, D. B., Soveny, C., and Morstyn, G. Effects ofbombesin antagonists on the growth of small cell lung cancer cells in vitro.Cancer Res., 48: 4783-4789. 1988.

    49. Woll. P. J., and Rozengurt. E. [D-Arg'.D-Phe5,D-Trp7-',Leu"]substance P. a

    potent bombesin antagonist in murine Swiss 3T3 cells, inhibits the growthof human small cell lung cancer cells in vivo. Proc. Nati. Acad. Sci. USA, 85:1859-1863, 1988.

    50. Trepel, J. B., Moyer, J. D., Cuttitta, F., Frucht, H., Coy, D. H„Natale, R.B., Mulshine. J. L., Jensen, R. T., and Sausville, E. A. A novel bombesinreceptor antagonist inhibits autocrine signals in a small cell lung cancer cellline. Biochem. Biophys. Res. Commun., 756: 1383-1389, 1988.

    51. Woll, P. J., and Rozengurt. E. Multiple neuropeptides mobilise calcium insmall cell lung cancer: effects of vasopressin. bradykinin. cholecystokinin.galanin, and neurotensin. Biochem. Biophys. Res. Commun., 164: 66-73.1989.

    5262

    on June 3, 2021. © 1990 American Association for Cancer Research. cancerres.aacrjournals.org Downloaded from

    http://cancerres.aacrjournals.org/

  • 1990;50:5257-5262. Cancer Res Yoav Sharoni, Jean Viallet, Jane B. Trepel, et al. from Swiss 3T3 and Small Cell Lung Carcinoma CellsBombesin-stimulated Phospholipase C Activity in Membranes Effect of Guanine and Adenine Nucleotides on

    Updated version

    http://cancerres.aacrjournals.org/content/50/17/5257

    Access the most recent version of this article at:

    E-mail alerts related to this article or journal.Sign up to receive free email-alerts

    Subscriptions

    Reprints and

    [email protected] at

    To order reprints of this article or to subscribe to the journal, contact the AACR Publications

    Permissions

    Rightslink site. Click on "Request Permissions" which will take you to the Copyright Clearance Center's (CCC)

    .http://cancerres.aacrjournals.org/content/50/17/5257To request permission to re-use all or part of this article, use this link

    on June 3, 2021. © 1990 American Association for Cancer Research. cancerres.aacrjournals.org Downloaded from

    http://cancerres.aacrjournals.org/content/50/17/5257http://cancerres.aacrjournals.org/cgi/alertsmailto:[email protected]://cancerres.aacrjournals.org/content/50/17/5257http://cancerres.aacrjournals.org/